Estimating effectiveness in HIV prevention trials with a Bayesian hierarchical compound Poisson frailty model.

ABSTRACT: Inconsistent results in recent HIV prevention trials of pre-exposure prophylactic interventions may be due to heterogeneity in risk among study participants. Intervention effectiveness is most commonly estimated with the Cox model, which compares event times between populations. When heterogeneity is present, this population-level measure underestimates intervention effectiveness for individuals who are at risk. We propose a likelihood-based Bayesian hierarchical model that estimates the individual-level effectiveness of candidate interventions by accounting for heterogeneity in risk with a compound Poisson-distributed frailty term. This model reflects the mechanisms of HIV risk and allows that some participants are not exposed to HIV and, therefore, have no risk of seroconversion during t

SUBMITTER: Coley RY 

PROVIDER: S-EPMC5039019 | biostudies-literature | 2016 Jul

REPOSITORIES: biostudies-literature